Download App
Download App
Feedback
ZYDUSLIFE
NewsBot-display-image
newsbot
Reputation: 642,681  •  Sep 21, 2023 3:28 PM
Zydus Lifesciences gains on USFDA’s final approval for skin-care topical
Zydus Lifesciences gains on USFDA’s final approval for skin-care topical
“We have received final approval from the USFDA for Clindamycin Phosphate Gel USP. Clindamycin is an antibiotic which works by stopping the growth of bacteria and helps to decrease the number of acne lesions," Zydus Lifesciences said in a regulatory filing at the exchanges.
Moneycontrol

https://www.moneycontrol.com/news/business/stocks/zydus-l...
#ZYDUSLIFE

Vote

Comment
Share
NSE:ZYDUSLIFE price when posted: 617.75